Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Align Technology (ALGN) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical Instruments & SuppliesALGN

Latest price · Nov 20, 2026 $157.12 -1.6% on the day · +18.3% over 12 months 52-week range $132.81 – $197.51
Get ALGN alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling1last 12 months
Reported sales$1.5M0 of 1 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 27, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale John Morici, CFO sold 7,969 shares at $189.31 ($1.5M).

Trade date
Feb 18, 2026
Disclosed to the SEC
Feb 20, 2026
Type
Sale (code S)

Read the original SEC filing ↗All ALGN insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

ALGN insider transactions (Form 4)

Open-market purchases and sales. 18 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Feb 20SEC John MoriciCFO Sell 7,9698,237 held (−49%) $189.31 $1.5M -17.0% —
Historical context

Similar past setups: not applicable. ALGN has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with ALGN in the Research Lab

ALGN has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

ALGN closeInsider buyInsider sale
120140160180200DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-04-29EEarnings release filed 2026-07-29EEarnings release filed 2026-10-28Sold $1,508,646 on 2026-02-18 · John Morici
Bought, 12 months$0
Sold, 12 months$1.5M
Insiders buying0
Insiders selling1

Align Technology insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $1.5M of ALGN stock on the open market; P/E 24.1 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

ALGN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $1.5M sold (1 trades)Q1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026—0$1.5M1

Valuation, profit and volume

P/E (trailing)24.1Sector median 25.0
Market value$11.66BMedical Instruments & Supplies
Profit margin11.8%Revenue growth +1.9%
Volume vs. 50-day0.8×Last 5 sessions

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Align Technology insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $1.5M. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

ALGN earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 28, 2026 +8.2% None +1.2%S&P -0.0% pending
Jul 29, 2026 -2.8% None -1.2%S&P +0.1% -9.1%
Apr 29, 2026 -1.9% None -0.7%S&P +1.0% -0.6%
Feb 4, 2026 -8.4% None +11.8%S&P -1.7% -0.9%
Oct 29, 2025 +2.8% None +4.0%S&P -1.1% +6.3%
Jul 30, 2025 +3.3% None -37.3%S&P -0.5% +10.0%
Apr 30, 2025 +7.3% None -0.6%S&P +0.7% +2.4%
Feb 5, 2025 -4.2% None +1.7%S&P +0.8% -20.4%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

ALGN short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

Rising
20%40%60%2026-08-26: 34% of volume sold short2026-08-27: 47% of volume sold short2026-08-28: 28% of volume sold short2026-08-31: 54% of volume sold short2026-09-01: 64% of volume sold short2026-09-02: 59% of volume sold short2026-09-03: 63% of volume sold short2026-09-04: 66% of volume sold short2026-09-08: 58% of volume sold short2026-09-09: 61% of volume sold short2026-09-10: 69% of volume sold short2026-09-11: 83% of volume sold short2026-09-14: 59% of volume sold short2026-09-15: 66% of volume sold short2026-09-16: 68% of volume sold short2026-09-17: 73% of volume sold short2026-09-18: 74% of volume sold short2026-09-21: 63% of volume sold short2026-09-22: 61% of volume sold short2026-09-23: 31% of volume sold short2026-09-24: 63% of volume sold short2026-09-25: 46% of volume sold short2026-09-28: 58% of volume sold short2026-09-29: 71% of volume sold short2026-09-30: 73% of volume sold short2026-10-01: 67% of volume sold short2026-10-02: 67% of volume sold short2026-10-05: 69% of volume sold short2026-10-06: 75% of volume sold short2026-10-07: 69% of volume sold short2026-10-08: 50% of volume sold short2026-10-09: 66% of volume sold short2026-10-12: 65% of volume sold short2026-10-13: 79% of volume sold short2026-10-14: 71% of volume sold short2026-10-15: 67% of volume sold short2026-10-16: 60% of volume sold short2026-10-19: 71% of volume sold short2026-10-20: 55% of volume sold short2026-10-21: 76% of volume sold short2026-10-22: 63% of volume sold short2026-10-23: 63% of volume sold short2026-10-26: 60% of volume sold short2026-10-27: 47% of volume sold short2026-10-28: 69% of volume sold short2026-10-29: 79% of volume sold short2026-10-30: 61% of volume sold short2026-11-02: 69% of volume sold short2026-11-03: 57% of volume sold short2026-11-04: 45% of volume sold short2026-11-05: 74% of volume sold short2026-11-06: 72% of volume sold short2026-11-09: 71% of volume sold short2026-11-10: 75% of volume sold short2026-11-11: 69% of volume sold short2026-11-12: 70% of volume sold short2026-11-13: 71% of volume sold short2026-11-16: 63% of volume sold short2026-11-17: 67% of volume sold short2026-11-18: 80% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 80%20-day average: 67%Prior 2 months: 62%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Insiders at Align Technology

InsiderBoughtSoldLast filingPast buys beat S&PScore
John MoriciCFO — $1.5M Feb 24, 2026 0 of 1 —
George J. MorrowDirector — — May 22, 2026 — —
Kevin T. ConroyDirector — — May 22, 2026 — —
Joseph LacobDirector — — May 22, 2026 — —
Kevin J. DallasDirector — — May 22, 2026 1 of 1 —
C. Raymond Larkin Jr.Director — — May 22, 2026 0 of 2 —
Anne MyongDirector — — May 22, 2026 1 of 1 —
Mojdeh PoulDirector — — May 22, 2026 — —
Andrea Lynn SaiaDirector — — May 22, 2026 — —
Susan E. SiegelDirector — — May 22, 2026 — —
Britt J. VitaloneDirector — — May 22, 2026 — —
Joseph M. HoganCEO, President — — Feb 24, 2026 2 of 5 —
Julie Ann ColettiGeneral Counsel — — Feb 24, 2026 — —
Stuart A. HockridgeEvp, Global Hr — — Feb 24, 2026 — —

Board links: companies that share insiders with ALGN

Directors and executives who filed Form 4s for ALGN and another company in the last 12 months.

See the map →
  • ILMNIllumina Julie Ann Coletti General Counsel here · General Counsel at ILMN · latest filing Sep 10, 2026Susan E. Siegel Director here · Director at ILMN · latest filing May 22, 2026
  • ABTAbbott Laboratories Kevin T. Conroy Director here · Director at ABT · latest filing Sep 25, 2026
  • MCKMcKesson Britt J. Vitalone Director here · CFO at MCK · latest filing May 27, 2026
  • NBIXNeurocrine Biosciences George J. Morrow Director here · Director at NBIX · latest filing Nov 3, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

ALGN stock: common questions

Are Align Technology insiders buying ALGN stock?

No. No Align Technology insider reported an open-market purchase of ALGN in the past 12 months.

Are Align Technology insiders selling ALGN stock?

1 insider reported sales worth $1.5M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ALGN's P/E ratio?

ALGN trades at about 24.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is ALGN's 52-week range?

Over the past year ALGN has traded between $132.81 and $197.51. It last closed at $157.12 on Nov 20, 2026.